Quality of life, cancer investigation, and clinical practice

Cancer Investigation

Volumn 16, Issue 7, 1998, Pages 478-484

  Fairclough, Diane L ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER PATIENT; CANCER RESEARCH; CANCER SURVIVAL; CLINICAL PRACTICE; HUMAN; MEDICAL DECISION MAKING; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE;

EID: 0031662121     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909809011702     Document Type: Article

References (35)

1. Moinpour CM, Feigl P, Metch B, et al: Quality of life endpoints in cancer clinical trials: review and recommendations. J Natl Cancer Inst 81:485-495.
2. Mayfield SG, Hailey BJ: Quality of life assessment in cancer clinical trials: report of the workshop on quality of life research in cancer clinical trials. National Cancer Institute: Bethesda, MD, 1990.
3. Gotay CC, Korn EL, McCabe MS, et al: Quality-of-life assessment in cancer treatment protocols: research issues in protocol development. J Natl Cancer Inst 84:575-579, 1992.
4. Gotay CC, Korn EL, McCabe MS, et al: Building quality-of-life assessment into cancer treatment studies. Oncology 6:25-28, 1992.
5. Yabroff KR, Linas BP, Schulman K: Evaluation of quality of life for diverse patient populations. Breast Cancer Res Treat 40:87-104, 1996.
6. Schipper H, Clinich J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index - Cancer: development and validation. J Clin Oncol 2:472-482, 1984.
7. Aaronson NK, Ahmedzai S, Bergman B, et al: The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:65-75, 1993.
8. Cella DF, Tulsky DS, Gray G, et al: The functional assessment of cancer therapy scale. Development and validation of the general measure. J Clin Oncol 11:570-579, 1993.
9. McNeil BJ, Weichselbaum R, Pauker SG: Tradeoffs between quality and quantity of life in laryngeal cancer. N Engl J Med 305:982-987, 1981.
10. Torrance GW, Thomas WH, Sackett DL: A utility maximizing model for evaluation of health care programs. Health Serv Res 7: 118-133, 1971.
11. Feeny D, Furlong W, Barr RD, et al: A comprehensive multi-attribute system for classifying the health status of survivors of childhood cancer. J Clin Oncol 10:923-928, 1992.
12. Weeks J: Quality-of-Life Assessment: performance status up-staged? J Clin Oncol 10:1827-1829, 1992.
13. Goldhirsch A, Gelber RD, Simes RJ, et al: Costs and benefits of adjuvant therapy in breast cancer: a quality adjusted survival analysis. J Clin Oncol 7:36-44, 1989.
14. Glasziou PP, Simes RJ, Gelber RD: Quality-adjusted survival analysis. Stat Med 9:1259-1276, 1990.
15. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. 1st Ed. Ottawa, 1994.
16. Helgason AR, Adolfsson J, Dickman P, et al: Waning sexual function - the most important disease-specific distress for patients with prostate cancer. Br J Cancer 73:1417-1421, 1996.
17. Barr RD, Pai MKR, Weitzman S, et al: A multi-attribute approach to health status measurement and clinical management - illustrated by an application to brain tumors in childhood. Int J Oncol 4: 639-648, 1994.
18. National Wilms' Tumor Study Committee: Wilms' Tumor Status Report, 1990. J Clin Oncol 9:877-887, 1991.
19. Kornblith AB, Herr HW, Ofman US, et al: Quality of life of patients with prostate cancer and their spouses. Cancer 73:2791-2802, 1994.
20. Slevin ML: Quality of life. Philosophical question or clinical reality. Br Med J 305:466-469, 1992.
21. Coates A, Gebski V, Stat M, et al: Improving the quality of life during chemotherapy of advanced breast cancer: a comparison of intermittent and continuous treatment strategies. N Engl J Med 317:1490-1495, 1987.
22. Gelber RD, Goldhirsch A, Hurny C, et al: Quality of life in clinical trials of adjuvant therapies. JNCI Monogr 11:127-135, 1992
23. Kassa S, Mastekaasa A, Lund E: Prognostic factors for patients with inoperable non-small cell lung cancer, limited disease. Radiother Oncol 15L:235-242, 1989.
24. Ruchdeschel JC, Pinantadosi S: Quality of life assessment in lung surgery for bronchogenic carcinoma. J Theor Surg 6:201-205, 1991.
25. Coates A, Gebski V, Signorini D, et al: Prognostic value of quality-of-life scores during chemotherapy for advance breast cancer. J Clin Oncol 10:1833-1838, 1992.
26. Osoba D, Zee B, Sadura A, et al: Measurement of quality of life in an adjuvant trial of gamma interferon versus levamisole in malignant melanoma. In: Adjuvant Therapy of Cancer. Vol 7, edited by SE Salmon. Philadelphia, JB Lippincott, 1993, pp. 412-416.
27. Loprinzi CL, Laurie JA, Wieand S, et al: Prospective evaluation of prognostic variables from patient-completed questionnaires. J Clin Oncol 12:601-607, 1994.
28. Sedman AD, Porteney R, Yao TJ, et al: Quality of life in phase II trials: a study of methodology and predictive value in patients with advance breast cancer treated with paclitaxel plus granulocyte colony stimulating factor. J Nat Cancer Inst 87:1316-1322, 1995.
29. Earlam S, Glover C, Fordy C, et al: Relation between tumor size, quality of life and survival in patients with colorectal liver metastases. J Clin Oncol 14:171-175, 1996.
30. Cella DF, Fairclough DL, Bonomi P, et al: Quality of life in advance non-small cell lung cancer: results from Eastern Cooperative Oncology Group study 5592. Proc Am Soc Clin Oncol 16: 2a, 1997 (abstract).
31. Slevin ML, Plant H, Lynch D, et al: Who should measure quality of life, the doctor or the patient? Br J Cancer 57:109-112, 1988.
32. Osoba D, Zee B, Pater J, et al: Determinants of post-chemotherapy nausea and vomiting in patients with cancer. J Clin Oncol 15: 116-123, 1997.
33. McNeil BJ, Weishelbaum R, Pauker SG: Fallacy of the five-year survival in lung cancer N Engl J Med 299:1397-1401, 1978.
34. Osoba D, Rodrigues G, Myles J, Z et al: Interpreting the significance of changes in health-related quality of life scores. J Clin Oncol 16:139-144, 1998.
35. Osoba D. Measuring the effect of cancer on health-related quality of life. Pharmacoeconomics 7:308-391, 1995.